Detalles de la búsqueda
1.
Inflammatory breast cancer cells are characterized by abrogated TGFß1-dependent cell motility and SMAD3 activity.
Breast Cancer Res Treat
; 180(2): 385-395, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32043194
2.
Deciphering the molecular biology of inflammatory breast cancer through molecular characterization of patient samples and preclinical models.
Int Rev Cell Mol Biol
; 384: 77-112, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38637101
3.
Measurement of LAG-3 Expression Across Multiple Staining Platforms With the 17B4 Antibody Clone.
Arch Pathol Lab Med
; 147(11): 1307-1314, 2023 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36745202
4.
Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC.
NPJ Breast Cancer
; 8(1): 12, 2022 Jan 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35042871
5.
The Evolution and Prognostic Role of Tumour-Infiltrating Lymphocytes and Peripheral Blood-Based Biomarkers in Inflammatory Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
Cancers (Basel)
; 13(18)2021 Sep 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34572883
6.
NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non-inflammatory breast cancers.
Mol Oncol
; 14(3): 504-519, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31854063
7.
Inflammatory breast cancer tumor emboli express high levels of anti-apoptotic proteins: use of a quantitative high content and high-throughput 3D IBC spheroid assay to identify targeting strategies.
Oncotarget
; 8(16): 25848-25863, 2017 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-28460441
Resultados
1 -
7
de 7
1
Próxima >
>>